Ethylmalonic encephalopathy: Clinical course and therapy response in an uncommon mild case with a severe ETHE1 mutation
- PMID: 32923369
- PMCID: PMC7476058
- DOI: 10.1016/j.ymgmr.2020.100641
Ethylmalonic encephalopathy: Clinical course and therapy response in an uncommon mild case with a severe ETHE1 mutation
Abstract
Ethylmalonic encephalopathy (EE) is a rare metabolic disorder caused by dysfunction of ETHE1 protein, a mitochondrial dioxygenase involved in hydrogen sulfide (H2S) detoxification. EE is usually a fatal disease with a severe clinical course mainly associated with developmental delay and regression, recurrent petechiae, orthostatic acrocyanosis, and chronic diarrhoea. Treatment includes antioxidants, antibiotics that lower H2S levels and antispastic medications, which are not curative. The mutations causing absence of the ETHE1 protein, as is the case for the described patient, usually entail a severe fatal phenotype. Although there are rare reported cases with mild clinical findings, the mechanism leading to these milder cases is also unclear. Here, we describe an 11-year-old boy with an ETHE1 gene mutation who has no neurocognitive impairment but chronic diarrhoea, which is controlled by oral medical treatment, and progressive spastic paraparesis that responded to Achilles tendon lengthening.
Keywords: 3-MST, 3-mercaptopyruvate sulfurtransferase; CAT, cysteine aminotransferase; CBS, cystathionine β-synthase; CSE, cystathionine γ-lyase; EE, ethylmalonic encephalopathy; EMA, ethylmalonic acid; ETHE1 gene; GSH, glutathione; H2S; H2S, hydrogen sulfide; H2SO3, persulfide; MTZ, metronidazole; Mild course; NAC, N-acetylcysteine; SCAD, short-chain acyl-CoA dehydrogenase; SDO, sulfur dioxygenase; SQR, sulfide quinone oxidoreductase; SUOX, sulfite oxidase; TST, thiosulfate sulfur transferase; Therapy response; UQ, quinone; cIII, complex III; cIV, complex IV.
© 2020 The Author(s).
Conflict of interest statement
The authors have no competing interests to declare.
Figures


Similar articles
-
Ethylmalonic Encephalopathy: a literature review and two new cases of mild phenotype.Neurol Sci. 2023 Nov;44(11):3827-3852. doi: 10.1007/s10072-023-06904-8. Epub 2023 Jul 17. Neurol Sci. 2023. PMID: 37458841 Review.
-
Response to medical and a novel dietary treatment in newborn screen identified patients with ethylmalonic encephalopathy.Mol Genet Metab. 2018 May;124(1):57-63. doi: 10.1016/j.ymgme.2018.02.008. Epub 2018 Feb 14. Mol Genet Metab. 2018. PMID: 29526615
-
Loss of ETHE1, a mitochondrial dioxygenase, causes fatal sulfide toxicity in ethylmalonic encephalopathy.Nat Med. 2009 Feb;15(2):200-5. doi: 10.1038/nm.1907. Epub 2009 Jan 11. Nat Med. 2009. PMID: 19136963
-
Sequential Accumulation of 'Driver' Pathway Mutations Induces the Upregulation of Hydrogen-Sulfide-Producing Enzymes in Human Colonic Epithelial Cell Organoids.Antioxidants (Basel). 2022 Sep 15;11(9):1823. doi: 10.3390/antiox11091823. Antioxidants (Basel). 2022. PMID: 36139896 Free PMC article.
-
Emerging roles of hydrogen sulfide-metabolizing enzymes in cancer.Redox Rep. 2024 Dec;29(1):2437338. doi: 10.1080/13510002.2024.2437338. Epub 2024 Dec 6. Redox Rep. 2024. PMID: 39643979 Free PMC article. Review.
Cited by
-
Essential role of sulfide oxidation in brain health and neurological disorders.Pharmacol Ther. 2025 Feb;266:108787. doi: 10.1016/j.pharmthera.2024.108787. Epub 2024 Dec 22. Pharmacol Ther. 2025. PMID: 39719173 Review.
-
Mitigation of depleted uranium-induced mitochondrial damage by ethylmalonic encephalopathy 1 protein via modulation of hydrogen sulfide and glutathione pathways.Arch Toxicol. 2025 Mar;99(3):1133-1141. doi: 10.1007/s00204-024-03949-2. Epub 2024 Dec 27. Arch Toxicol. 2025. PMID: 39729112
-
A case report of atypical ethylmalonic encephalopathy with peripheral neuropathy.CNS Neurosci Ther. 2023 Mar;29(3):971-973. doi: 10.1111/cns.14072. Epub 2023 Jan 4. CNS Neurosci Ther. 2023. PMID: 36601669 Free PMC article. No abstract available.
-
Overproduction of hydrogen sulfide, generated by cystathionine β-synthase, disrupts brain wave patterns and contributes to neurobehavioral dysfunction in a rat model of down syndrome.Redox Biol. 2022 May;51:102233. doi: 10.1016/j.redox.2022.102233. Epub 2022 Jan 13. Redox Biol. 2022. PMID: 35042677 Free PMC article.
-
Clinical and biochemical footprints of inherited metabolic disorders. XI. Gastrointestinal symptoms.Mol Genet Metab. 2023 Mar;138(3):107528. doi: 10.1016/j.ymgme.2023.107528. Epub 2023 Feb 1. Mol Genet Metab. 2023. PMID: 36774919 Free PMC article. Review.
References
-
- Tiranti V., D’Adamo P., Briem E., Ferrari G., Mineri R., Lamantea E., Mandel H., Balestri P., Garcia-Silva M.T., Vollmer B., Rinaldo P., Hahn S.H., Leonard J., Rahman S., Dionisi-Vici C., Garavaglia B., Gasparini P., Zeviani M. Ethylmalonic encephalopathy is caused by mutations in ETHE1, a gene encoding a mitochondrial matrix protein. Am. J. Hum. Genet. 2004;74:239–252. doi: 10.1086/381653. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous